Filing Flows

Filing Flows › Centene (CNC) › Q2 2026 › vs Q2 2025

Centene (CNC) Q2 2026 vs Q2 2025 (year over year)

Centene's revenue rose $4.8B (+10%) from $48.7B in Q2 2025 to $53.6B in Q2 2026. The biggest changes: Medicaid +$4.0B (+14%); Medicare +$1.6B (+17%); Commercial −$714M (-7%). Gross margin 8.6% against 6.2% (+2.4 pts).

Centene, Q2 2026: revenue $53.6B (+10% year over year), operating margin 2.2%, net earnings $1.1B, operating cash flow $3.6B. The chart draws each line against Q2 2025, the increases inside each band.

Centene: what changed, Q2 2026 vs Q2 2025Centene: what changed, Q2 2026 vs Q2 2025Medicaid$4.0BCost of revenue$3.2BFree cash flow (OCF − capex)$1.8BOperating cash flow$1.8BPre-tax earnings$1.7BOperating profit$1.7BMedicare$1.6BGross profit$1.6BNet earnings$1.3BCommercial−$714M

Margins

Q2 2026Q2 2025Change
Gross margin8.6%6.2%+2.4 pts
Operating margin2.2%-0.9%+3.2 pts
Net margin2.0%-0.5%+2.6 pts
Free cash flow margin6.4%3.2%+3.1 pts

Every line

LineQ2 2026Q2 2025Change%
Medicaid$32.0B$28.0B$4.0B+14%
Medicare$11.1B$9.4B$1.6B+17%
Commercial$9.4B$10.1B−$714M-7%
Other$1.2B$1.2B−$28.0M-2%
Revenue$53.6B$48.7B$4.8B+10%
Gross profit$4.6B$3.0B$1.6B+53%
Cost of revenue$49.0B$45.7B$3.2B+7%
Other income, net$288M$201M$87.0M+43%
Operating profit$1.2B−$458M$1.7B—
Operating expenses$3.4B$3.5B−$57.0M-2%
Pre-tax earnings$1.5B−$257M$1.7B—
SG&A$3.1B$3.0B$67.0M+2%
Other operating costs$316M$440M−$124M-28%
Net earnings$1.1B−$259M$1.3B—
Income tax$399M$2.0M$397M200×
Depreciation & amortization$300M$315M−$15.0M-5%
Share-based compensation$59.0M$35.0M$24.0M+69%
Working capital & other$2.1B$1.7B$450M+27%
Operating cash flow$3.6B$1.8B$1.8B+101%
Free cash flow (OCF − capex)$3.4B$1.6B$1.8B+117%
Capital expenditures$174M$208M−$34.0M-16%

Questions

How much did Centene's revenue grow year over year in Q2 2026?

Centene's revenue rose $4.8B (+10%) from $48.7B in Q2 2025 to $53.6B in Q2 2026.

What drove Centene's revenue change in Q2 2026?

Medicaid +$4.0B (+14%); Medicare +$1.6B (+17%); Commercial −$714M (-7%).

Q2 2026 results → · Compare in the interactive Sankey →